ROCK CREEK PHARMACEUTICALS, INC.
Healthcare · Medicinal Chemicals & Botanical Products · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$11.3M | −$32.6M | −$26.4M | −$21.2M | −$37.8M | −$28.2M |
| Net income | −$6.8M | −$38.5M | −$8.2M | −$5.2M | −$38.0M | −$28.3M |
| Total assets | $19.5M | $8.9M | $11.0M | $31.9M | $17.1M | $20.3M |
| Total liabilities | $30.2M | $19.8M | $4.0M | $6.9M | $7.7M | $9.6M |
| Equity | −$10.6M | −$10.8M | $7.0M | $25.0M | $9.4M | $10.7M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 201.7M | 172.6M | 166.5M | 145.6M | 139.3M | 127.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- —
- Net margin
- —
- Return on equity
- 64.3%
- Return on assets
- −35.0%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 154.5%
- Debt / equity
- —
- Book value / share
- $-0.05
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- -63.05distress
- Accruals / assets
- 2.3%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 2 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 12, 2015
- NT 10-Kmissed a reporting deadline ↗Mar 16, 2004
- NT 10-Kmissed a reporting deadline ↗Apr 1, 1999
- NT 10-Kmissed a reporting deadline ↗Mar 30, 1998
- NT 10-Qmissed a reporting deadline ↗Nov 14, 1996
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Scannell RobertDirector | Mar 30, 2016 | Buy | 285,714 | $0.35 |
| Tradewinds Capital, L.P.10% owner | Apr 2, 2014 | J | 1.6M | $0.00 |
| Tradewinds Master Fund (Bvi) Ltd.10% owner | Apr 2, 2014 | J | 5.6M | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivershipSep 28, 2016
- Debt acceleration / triggering eventAug 29, 2016
- Shareholder voteAug 17, 2016
- Director / officer changeJul 8, 2016
- Entered a material agreementJul 8, 2016
- Results of operations · Regulation FD disclosureMay 16, 2016
- Director / officer changeApr 5, 2016
- Entered a material agreement · Unregistered equity saleMar 31, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDFeb 14, 2023
- 8-KFORM 8-KSep 28, 2016
- 8-KFORM 8-KAug 29, 2016
- 8-KFORM 8-KAug 17, 2016
- 10-QFORM 10-QAug 10, 2016
- DEF 14AJul 22, 2016
- PRE 14AJul 11, 2016
- 8-KFORM 8-KJul 8, 2016
- 8-KFORM 8-KJul 8, 2016
- DEFA14AFORM 8-KJul 8, 2016
- 8-KMay 16, 2016
- S-8May 16, 2016
- 10-QFORM 10-QMay 16, 2016
- 424B3Apr 29, 2016
- 10-K/AFORM 10-K/AApr 29, 2016